FDA Says Sun's Elepsia Approval Was Erroneous
This article was originally published in Scrip
Executive Summary
The US FDA has stated that its earlier approval of Elepsia XR (levetiracetam extended-release tablets), the new drug application (NDA) of Sun Pharma Advanced Research Company Ltd (SPARC), was "erroneous."